Consultation on transparency in clinical trials

The European Medicines Agency (EMA) has launched a public consultation on how to implement the transparency requirements of the new EU Clinical Trials Regulation. The requirements must be implemented in the database for clinical trials, which the EMA is establishing together with the member states.

Draft proposal for an addendum, on transparency, to the “functional specifications for the EMA portal and EU database to be audited

EMA's press release

Deadline 18 February

All stakeholders are invited to send comments using this template to gcp@ema.europa.eu by close of business on 18 February 2015.